Vaccine Schedule Comparison: UIP vs IAP in India
How India's government Universal Immunization Programme schedule compares with the IAP's expanded private-clinic vaccine schedule, disease by disease.
This vaccine schedule comparison matters for a hospital or clinic administrator because it determines two different procurement and counselling conversations: what the government supplies free through routine immunization sessions, and what a family must be counselled to source separately if they want the IAP-recommended additions.
What diseases does the government's UIP schedule actually cover?
The UIP provides free immunization against nine vaccine-preventable diseases nationwide: diphtheria, pertussis, tetanus, polio, measles, rubella, severe childhood tuberculosis, hepatitis B, and Hib-related meningitis and pneumonia. Three further diseases, rotavirus diarrhoea, pneumococcal pneumonia and Japanese encephalitis, are covered sub-nationally rather than everywhere.
The programme reaches close to 2.67 crore newborns and 2.9 crore pregnant women annually, delivered through BCG, OPV, hepatitis B, pentavalent (DPT-Hib-HepB combined), IPV, PCV, rotavirus and MR vaccines administered from birth through age 16.
What does the IAP schedule add on top of UIP?
The IAP's 2025 Advisory Committee on Vaccines and Immunization Practices schedule recommends several vaccines beyond UIP's coverage: varicella, hepatitis A, typhoid conjugate vaccine, the MMR formulation containing mumps specifically, influenza, and HPV. These are available mainly at private clinics rather than through government immunization sessions.
The 2025 update specifically added a recommendation for HPV vaccination in boys as well as girls, a 2-dose 9-valent HPV schedule for ages 9–14, and a switch from quadrivalent to trivalent influenza vaccine formulations following updated strain guidance. None of these currently sit inside the free government schedule.
Why does the same disease sometimes appear on both schedules with different vaccine types?
Measles and rubella protection is a useful example: UIP delivers this through its MR vaccine dose, while IAP's schedule recommends an MMR formulation that also protects against mumps specifically. Both protect against measles and rubella; the IAP version adds mumps coverage that the government schedule does not currently include nationally.
This pattern, a shared core antigen with a private-schedule addition layered on top, repeats across several vaccine categories and is the main source of confusion for parents comparing the two schedules side by side rather than reading them as complementary.
Does IAP recommend anything UIP doesn't cover even sub-nationally?
Yes. Typhoid conjugate vaccine, varicella, hepatitis A and HPV sit in the IAP schedule with no equivalent anywhere in the current UIP structure, national or sub-national. This is the genuine coverage gap rather than a formulation difference, and it is where a family choosing to follow IAP's full recommended schedule incurs cost the government programme does not offset at all.
A hospital or clinic advising a family on vaccination should be explicit about which category a given recommendation falls into: a government-covered antigen, a government-covered antigen with a private upgrade, or a private-only addition with no government equivalent.
How often does either schedule actually change?
Both schedules are revised periodically as evidence and strain surveillance evolve; IAP's ACVIP publishes an updated schedule with accompanying rationale most years, with the 2025 update specifically revising HPV recommendations for boys and the influenza vaccine valency based on circulating strain data. UIP additions, such as the sub-national rollout of rotavirus, PCV and JE vaccines, have been phased in over successive years as manufacturing capacity and state-level need were assessed.
This means a "vaccine schedule comparison" done even two years ago may already be out of date on specific antigen additions, which is why a hospital's immunization counselling protocol needs a periodic refresh point built in, not a one-time reference document.
Why does this comparison matter for a hospital's vaccine stocking decisions?
A hospital or clinic running paediatric or antenatal immunization services stocks two categories side by side: UIP-aligned vaccines under the government programme, and IAP-recommended private vaccines a counselled family pays for directly. Getting the second category wrong, running out of a private vaccine right after counselling a parent to take it, sends that family and that revenue to an outside clinic instead.
Because immunization is a scheduled, predictable-visit service rather than an unpredictable prescription, it is one of the more forecastable categories for an in-house pharmacy to plan against. Medyzen's managed hospital pharmacy services piece covers how that stocking discipline is built, and the prescription leakage piece covers what it costs a hospital when a counselled, willing-to-pay family walks out for a vaccine the in-house pharmacy should have had ready. Our vaccine schedule guide covers each vaccine's individual timing and dose spacing in more detail.
Sources
- 1Universal Immunization Programme (UIP) — National Health Mission, Ministry of Health and Family Welfare
- 2Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices: Recommended Immunization Schedule (2025) — Indian Pediatrics, Springer Nature
- 3Indian Academy of Pediatrics (IAP) ACVIP: Recommended Immunization Schedule (2023) and Update — PubMed, National Institutes of Health
- 4Indian Academy of Pediatrics ACVIP recommended immunization schedule — Indian Pediatrics, official journal of the Indian Academy of Pediatrics
- 5Family Welfare Department — Routine Immunization (UIP) — Government of Manipur, reproducing national UIP schedule details
This article is for informational purposes and is not a substitute for professional medical advice. Schedule details are drawn from cited government and IAP sources current as of the date checked and are revised periodically. Consult a treating paediatrician for individual immunization decisions.
FAQ
Frequently asked questions
That is a clinical counselling decision for the treating paediatrician based on the family's risk factors and ability to pay; this comparison describes what each schedule covers rather than recommending one over the other.
The nine nationally covered diseases are free at government immunization sessions across India. The three sub-nationally covered diseases, rotavirus, pneumococcal disease and Japanese encephalitis, are free only in the states where they have been rolled out.
Typhoid conjugate vaccine, varicella, hepatitis A and HPV have no UIP equivalent, national or sub-national, and are available only through private clinics under the IAP schedule.
Yes. The 2025 update added an HPV recommendation for boys, a 2-dose 9-valent HPV regimen for ages 9–14, and a shift from quadrivalent to trivalent influenza vaccine based on updated circulating-strain guidance.
UIP's MR vaccine covers measles and rubella. IAP's recommended MMR formulation covers the same two diseases plus mumps, which is why the two appear similar but are not identical in coverage.
Dr. Rajesh IyerMBBS, MD (Pharmacology)
Clinical Pharmacologist
Dr. Rajesh Iyer is a clinical pharmacologist focusing on drug interactions, adverse-effect profiles, biosimilars, and drug-scheduling regulation in India.